Does social capital affect mental health, quality of life and disease control in diabetes patients from Côte d’Ivoire?

INTERVENTION: Patients will be randomized to two parallel arms (intervention and control arms) using blocked randomization in a gender‐stratified manner. 1. Intervention arm: Addition of a social supporter to the routine care provided at INSP. The diabetes patients will nominate one family member as a social supporter to accompany them to all care and educational sessions as prescribed by the patient’s treating physician at INSP 2. Control arm: Routine care provided at INSP Participants are followed up for 12 months CONDITION: Improving glycemic control and quality of life in patients with type 2 diabetes (T2D) ; Nutritional, Metabolic, Endocrine ; Type 2 diabetes mellitus PRIMARY OUTCOME: HbA1c measured using blood test 3 and 12 months SECONDARY OUTCOME: ; 1. HbA1c at baseline, 3 and 12 months; 2. Hypoglycemia event profile measured using patient (self‐tests) and hospital records after 3 and 12 months; 3. Quality of life measured using Depression, Anxiety and Stress Scale‐21 (DASS‐21) at baseline, 3 and 12 months; 4. Mental health status (depression, anxiety and stress) measured using WHO Quality of Life (WHOQOL‐BREF) Questionnaire at baseline, 3 and 12 months; INCLUSION CRITERIA: 1. Having a T2D diagnosed within the 3 months period prior INSP first visit 2. Receiving first prescription of antidiabetic drug from INSP 3. Aged 18 years or older and living in the city of Abidjan 4. Having no plan to move from home for the following 12 months 5. Living with family member or someone in the household 6. Access to a telephone